CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 43 enrolled
Drug / intervention
Arena Strive +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05653700
NCT05653700N/ACompleted
CompareCT.gov

Atrium Health - Arena Labs Research Protocol

Wake Forest University Health Sciences·interventional·Posted Dec 16, 2022·Updated Dec 4, 2024

In Brief

A clinical study evaluating Arena Strive and Control Cohort for Mental Health Disorder. Completed, enrolled 43 participants across 1 site.

Detailed Summary

To determine the efficacy of the asynchronous performance coaching platform, Arena Strive at changing measures of physiological resilience, professional fulfillment, burnout, and self-valuation in full time clinicians.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMental Health Disorder
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedDec 16, 2022
Enrollment StartMar 16, 2023
Primary CompletionJul 25, 2023
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.5 years ago

Interventions

Arena Strivedevice

This second-generation platform provides frontline clinicians with a comprehensive journey to access the tools, training, and technology used by other high-pressure fields to increase performance and enhance resilience. The experimental intervention employed in this study will be a 12-week, multi-phased approach involving an asynchronous learning and coaching experience (6 weeks), and exploration phase (6 weeks).

Control Cohortother

Participants randomized into the control cohort - survey at baseline and end of the study